WeVote
Log In

Bill

Bill

HB 1112

Prior authorization for opioid use disorder care.

2025 Regular Session Introduced by Garrett Bascom and 1 co-sponsor

Indiana bill streamlines insurance prior authorization for opioid addiction treatment to accelerate patient access to medication-assisted therapy and reduce care delays.

Committee report: amend do pass, adopted
#addictionservices;illicitdrugs #prescriptiondrugs #substances #andalcohol #healthcarefacilities;hospitals #healthcareprofessionals;physicalandoccupationaltherapists #health;behavioralhealth;mentalillnessandtreatment
0
WeVote Research Nonpartisan
Bill Summary · HB 1112

Legislative bill overview

HB 1112 regulates prior authorization requirements for opioid use disorder (OUD) treatment in Indiana. The bill aims to streamline insurance approval processes for medication-assisted treatment and other OUD care services, potentially reducing delays in patient access to these therapies.

Why is this important

Prior authorization delays can prevent timely access to addiction treatment when medical need is urgent, potentially contributing to overdose deaths or treatment dropout. OUD affects thousands of Hoosiers, and faster access to evidence-based care like methadone and buprenorphine maintenance directly impacts public health outcomes and mortality rates.

Potential points of contention

  • Insurance industry burden: Insurers may argue that eliminating or restricting prior authorization increases costs and reduces ability to manage fraud or inappropriate prescribing patterns
  • Scope definition: Disagreement over which OUD treatments should be exempt from authorization (medications only vs. counseling/behavioral services) and whether limits apply to all insurers or specific types
  • Implementation timeline: Questions about whether healthcare providers have adequate systems to handle expedited claims processing without operational disruption

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.